ABSTRACT
appear to require the covalent attachment of ubiquitin to other proteins.
The enzyme systems that accomplish this posttranslational modification have received much attention, and several recent reviews have summarized our understanding of the specificity and regulation of these processes (1-7). The ubiquitin conjugating reactions are intricately regulated and probably controlled by a complex interplay between the E2 or ubiquitin-conjugating enzymes (of which there appear to be at least 20 in mammals) and the E3 or ubiquitin ligases, numbering perhaps a dozen. The specificity of ubiquitination is thus a combinatorial process, depending on the exact combination of E2 and E3 enzymes expressed at a specific time and place in the cell. Ubiquitinated proteins are then targeted for specific localizations, including the proteasome. This 26S multicatalytic protease is responsible for hydrolyzing the targeted protein and releasing small peptides and free ubiquitin (or polyubiquitin).
Many important regulatory proteins and damaged proteins are degraded by this system (see reviews above).
As befits such a complicated conjugation reaction, there are now dozens of different known deubiquitinating enzymes (DUBs)2 ( Table 1) . These fall into two families, both thiol proteases with specificity for cleavage of the peptide bond at the carboxyl-terminal G76 of ubiquitin (4, 5, 8) . Evidence is rapidly accumulating that suggests these deubiquitinating enzymes are also highly regulated and specific components of the ubiquitination system and that they affect numerous vital cellular functions. The reversible ubiquitination of proteins is similar to the reversible phosphorylation of proteins and probably serves the same functions, which is to modify the structure, activity, or localization of the target protein.
To complete this analogy, the deubiquitinating enzymes are the 'phosphatases' of this system, and many lessons we have learned from the control of phosphorylation should be relevant. Here I shall review the developments over the past few years and attempt to summarize the evidence that DUBs are important regulatory enzymes. In general, only the original observation or the most recent findings will be referenced, and the reader is directed to earlier reviews for more comprehensive coverage. Other articles in this series will present experimental data to confirm and amplify these broad generalizations. 
S. cerevisiae

Structure and specificity of deubiquitinating enzymes
Ubiquitin carboxyl-terininal hydrolases
This family of proteins was the first to be identified and is the most extensively studied. The proteins were named for their activity in hydrolyzing small amides and esters at the carboxyl terminus of ubiquitin (13), and have subsequently been shown to also remove peptides and small proteins (13-17).
At least nine such sequences are known from different organisms (italics, Table 1 ). They have in common a 210 amino acid catalytic domain, with four very highly conserved blocks of sequence identifying these enzymes (Fig. 2) . Two UGH sequences have significant carboxyl-terminal extensions (see below). Three human UGH isozymes have been cloned; they exhibit marked tissue specificity.
For instance, UGH-L3 is a hematopoetic cell specific isoform, whereas UGH-Li is found at high levels in neural and diffuse neuroendocrine cells (10, 18). We recently published the crystal structure of human UCH-L3 (19). The core catalytic domain strongly resembles that of cathepsin B, a member of the papain family of thiol proteases (Fig. 3) 
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HIS BOX
Ubiquitin-specijic processing proteases
Using an assay to detect yeast enzymes that could deubiquitinate a ubiquitin--galactosidase fusion protein, Varshavsky and co-workers (11, 12) discovered the first three examples of a family of proteins they called ubiquitin-specific processing proteases (UBP). In addition to processing the fusion protein, these enzymes were also capable of processing the primary ubiquitin gene products, either in vitro or when coexpressed in bacteria.
These three enzymes are more distantly related than are UGH isozymes (Fig. 4) ; they are highly homologous in only two regions: the cys box and the his box (21, 22). When sequencing of the yeast genome was completed, it became apparent there are 16 such isozymes in yeast (Table 1 and Fig. 4) and that additional blocks of similarity are present. In Fig.  4 , the sequences are arranged by the distance between the cys box and the his box and then aligned at the active site cysteine. It is apparent that there is a core catalytic domain of about 450 amino acids delimited by the cys and his boxes. Many of these isoforms have amino-terminal extensions and a few have carboxyl-terminal extensions.
In addition, there are insertions in the catalytic domains of many of the isoforms. It is assumed that these extensions and insertions confer substrate specificity or control localization of the enzymes. Other organisms also have multiple DUB isozymes, with complete sequences known for S. poinbe (4), Didyosteiiurn (I), C. elegant (10), Aplysia (1), Drosophila (2), mouse (7), and hi.imans (12). All in all, there are 60 full-length DUB sequences identified to (late (Table 1) 
Proprotein processing
The identity of the DUB enzyme (or enzymes) responsible for ubiquitin proprotein and ubiquitin fusion protein (UbGEP) processing is unknown.
Several DUBs have been reported to process the uhiquitin fusion proteins in vitro, and several others appear able to cotranslationally process proubiquitin, uhiquitin fusion proteins, or both (11, 12, 22-25). In The active site C is in the black block whereas the active site H is in the first white block. The number at the amino terminus of these sequences refers to the UBP nomenclature in Table 1 (i.e., 1 is UBP1, 2 is UBP2, etc.) .Accession numbers are given in Table I .
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Metabolism
of the polyubiquitin degradation signal
The best-characterized function of DUB enzymes is the disassembly of the polyubiquitin degradation signal (22, 25). This form of polymeric ubiquitin is linked by isopeptide bonds between K48 on the proximal ubiquitin (i.e., the one closest to the target protein) and the carboxyl-terminal glycine of the more distal ubiquitin in the chain. After degradation of ubiquitinated proteins by the 26S protease, the residual peptide must be removed from the carboxyl terminus of the proximal ubiquitin and the chain must be disassembled by the action of deubiquitinating
enzymes. An isopeptidase activity associated with the PA700 regulatory subcomplex of the 26S proteasome has recently been described (26). This activity apparently shortens the polyubiquitin chain one subunit at a time from the distal end. This activity may be able to disassemble other polyubiquitin chains, but cannot hydrolyze the proubiquitin gene product. It is postulated that this is a proofreading enzyme that edits the ubiquitin chain by slowly shortening it. Proteins that carry only short polyubiquitin chains could have those chains removed by this activity before proteolysis could occur, whereas those that have longer chains would probably be hydrolyzed to amino acids by the proteasome before the PA700-associated activity could fully remove the chain. Thus, only proteins that had been completely ubiquitinated would be rapidly degraded. Such a reaction could explain the presence of enzymes that synthesize free polyubiquitin chains (31).
In summary, the reactions responsible for the metabolism of the polyubiquitin chain are designed to ensure that polyubiquitin chains do not accumulate to levels sufficient to inhibit the proteasome. Long polyubiquitin chains attached to substrates may be trimmed on the proteasome by PA700-associated activity. In addition to proofreading the chain length, such an activity may be necessary to allow release of the chain from the tight binding site on the proteasome upon completion of the proteolysis. Doa4 appears to be one of the enzymes responsible for removing the peptide fragment and generating a free carboxyl terminus on the chains. Finally, only when the degradation has been accomplished and the intermediate properly processed does isopeptidase T hydrolyze the chains to monomers. None of these reactions will remove the polyubiquitin chain before association of the substrate with the proteasome. If other enzymes are able to shorten or remove the chain on free polyubiquitinated substrates, they would be expected to be highly regulated to prevent loss of the degradation signal before degradation of the target protein.
Biological effects
DUBs have been shown to be involved in numerous biologically important processes including control of growth, differentiation, oncogenesis, and genome integrity.
Development
Several DUB enzymes have been shown to have important roles in development.
The product of the fat facets gene (faf) in Drosophila is required in the pathway of eye facet development (32). In its absence, a signal that directs the death of certain cells in the facet precluster is not generated and eyes develop with additional photoreceptor cells. These mutants also show defects in embryogenesis as well as ovary and testis development.
The signal is generated by cells outside the facet precluster and requires the catalytic cysteine of faf (33 
Growth and oncogenesis
Many substrates of the ubiquitin-dependent proteolytic system are regulators of cell growth or are oncogenic when mutated (2) . Thus, we expect a number of deubiquitinating enzymes will be shown to have roles in growth regulation.
Some have already and BRCA1 bind to each other and that overexpression of BAP1 augments the growth-suppressive effects of BRCA1. One attractive hypothesis to explain these interactions is that BRGA1 recruits BAP1 to a site where its deubiquitinating activity is required. BRCA1 also binds RAD51, a protein involved in recombination and double strand DNA repair (57) . RAD51 is localized to the synaptonemal complexes and binds both an ubiquitinating enzyme (58) and UBL, a ubiquitin-like protein (59) . The colocalization of these ubiquitin system components may be related to their roles in DNA repair, recombination, and chromosome segregation (see below). Finally, a truncated version of a human UBP, lie-2, is a dominant oncogene and has been shown to be tumorigenic (21, 52). Conversely, a nuclear DUB from mouse (Unp) and the human homolog (Unph) have been shown to act as proto-oncogenes (53) when overexpressed and to be elevated in lung cancers (60) . Overexpression, however, has no effect on overall proteolysis, suggesting a role in the deubiquitination of very specific substrates that act as growth regulators.
Thus, it appears that either inactivation or overexpression of various DUBs can be tumorigenic. This may be because several important regulatory proteins are substrates for ubiquitindependent processes, and either increased or decreased stability of such factors could disturb the growth regulatory processes.
Regulation of DNA and chromosome structure
It has long been known that a significant fraction of core histones are ubiquitinated and that deubiquitination of histones is important in chromatin condensation, especially that occurring at mitosis (50) Crude preparations of enzymes capable of removing the ubiquitin from ubiquitinated histone H2a have been reported (75), but the enzyme has never been cloned or sequenced and so it is not clear to which family it belongs. Recently, genetic evidence for the involvement of deubiquitinating enzymes in the regulation of chromosome structure has emerged. First, it was shown that Doa4 was necessary to coordinate DNA replication and limit it to one copy of the genome in yeast (27) . Overexpression of ubiquitin is necessary to restore the pool of free ubiquitin in mutant cells, but this is not sufficient to suppress the replication defect. This phenotype may be related to the observation that important regulators of ploidy (Rum 1 and Cdcl8 in yeast) are degraded by the ubiquitin-dependent system (76). Second, silencing of transcription at the silent mating type loci and telomeres is inhibited by Ubp3p, possibly involving the formation of a complex with the SIR4 protein in the SIR protein complex (77). Silencing is thought to be due to a change in chromatin structure, forming a heterochromatin-like state in the inhibited regions. A similar phenomenon also occurs in the silencing of Tyl elements inserted into the tandem array of RNA genes in yeast, as both SIR2 and a ubiquitin-conjugating enzyme have been shown to be necessary (78). Recently, UbplS has been implicated in the same pathway, but downstream of Ubp3 (R. T. Baker and R. D. Everett, unpublished).
Finally, in Drosophila, the gene dosage of a UBP (D-Ubp-64E) has been shown to affect position variegation (79). Genes inserted in different positions of the Drosophila genome show different levels of transcription, and this can be affected by the state of the chromatin at the site of integration.
Insertions at the interface between hetero-and euchromatin are susceptible to variable degrees of silencing in different cells due to variability in the spreading of the heterochromatin-like state, implicating DUBs in processes affecting the formation or maintenance of heterochromatin. A human UBP, HAUSP (80),binds to nuclear structurescalled ND1O, which contain PML (the proyelocytic leukemia protein).
It also binds to herpes VmwliO, a regulator of lytic gene expression.
Although the role of HAUSP is unknown, it is closely related to both Ubpl5 and D-Ubp-64E, suggesting the conservation of this pathway from yeast to humans.
Processing of ubiquitin-like proteins
In addition to ubiquitin, all eukaryotes contain several other ubiquitin-like proteins that can also be conjugated to proteins. These include viral proteins that can be conjugated to cellular proteins and may interfere with normal cellular ubiquitin-dependent processes (81); an interferon n-induced protein that is conjugated to numerous proteins and targets them to the cytoskeleton (82); a ubiquitin-like gene product, FAU, which is a protein with an amino-terminal ubiquitin-like domain fused to the ribosomal protein S30 and is a nonspecific immunosuppresor (83, 84); Nedd8, a developmentally regulated ubiquitin-like protein (85); and SUMO-i, a ubiquitin-like protein conjugated to cellular proteins and involved in nuclear import (72). SUMO-1 has been identified several times in various two-hybrid screens or biochemical analysis and has been called sentrin (86), UBL1 (59), PIC1 (87), GMP1 (73), and SMT3c (88). It has recently been shown that SUMO1 can be covalently attached to proteins and, in at least one case, result in the redistribution of this protein (73). Nuclear import requires a C-protein called RAN. As with other C-proteins, RAN requires a GTPase activator protein; a 70 kDa activator has been identified and named GAP-i. This protein exhibits an apparent molecular mass of 90 kDa when it is associated with the nuclear membrane.
Two groups have shown that this is due to covalent attachment of a new ubiquitin-like protein similar to the product of the yeast SMT3 locus (72, 73). An activity that reverses this conjugation has been detected in the nuclear membrane and is likely related to known deubiquitinating enzymes. All of these ubiquitin-like proteins are also synthesized as fusion proteins that must be processed by enzymes similar to deubiquitinating enzymes. It is likely that some of the known deubiquitinating enzymes will be responsible for processing these fusion proteins and disassembling the conjugated ubiquitinlike proteins.
These exciting findings suggest that other pathways of covalent protein ligation (using ubiquitin
IMPLICATIONS/SPECULATIONS
The scope and magnitude of these processes is astounding.
The ubiquitin domain is a versatile targeting signal that can be posttranslationally attached to a wide variety of proteins. The biological logic and complexity of this regulatory system suggest that deubiquitination will be an important regulatory step. Recent results have defined two very large families of deubiquitinating enzymes (DUBs), reinforced the importance of DUB enzymes, and suggested numerous surprising nuances of the system.
DUBs antagonize ubiquitination
and will probably regulate all ubiquitin-dependent pathways
We already know of a significant number of ubiquitin-dependent processes that are profoundly affected by the activity of DUBs. In addition, many of these enzymes have highly divergent structures, which suggests different substrates, localizations, or proteinprotein associations.
Finally, the complexity of regulatory logic demands that there must be ways to "proofread" ubiquitination and down-regulate it.
DUBs are probably targeted to specific locations
The DUBs are more notable for their differences than their similarities. 
